Several analysts have recently updated their ratings and price targets for Insmed (NASDAQ: INSM): 6/7/2024 – Insmed had its price target raised by analysts at Mizuho from $36.00 to $82.00. They now have a “buy” rating on the stock. 5/31/2024 – Insmed had its price target raised by analysts at Stifel Nicolaus from $39.00 to […]
Scout Investments Inc. lowered its holdings in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 293,197 shares of the biopharmaceutical company’s stock after selling 4,600 shares during the period. Scout Investments Inc. owned about 0.20% […]
Insmed Incorporated (NASDAQ:INSM – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 9,930,000 shares, a growth of 16.4% from the April 30th total of 8,530,000 shares. Based on an average daily volume of 1,760,000 shares, the […]
Eagle Asset Management Inc. lifted its stake in Insmed Incorporated (NASDAQ:INSM – Free Report) by 5.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 548,633 shares of the biopharmaceutical company’s stock after purchasing an additional 29,555 shares during the […]
Insmed (NASDAQ:INSM – Free Report) had its target price boosted by UBS Group from $46.00 to $58.00 in a research report released on Wednesday morning, Benzinga reports. UBS Group currently has a buy rating on the biopharmaceutical company’s stock. A number of other brokerages have also commented on INSM. The Goldman Sachs Group boosted their […]